KEGG   DRUG: Atazanavir and cobicistat
Entry
D10753            Mixture   Drug                                   

Name
Atazanavir and cobicistat;
Evotaz (TN)
Product
Component
(Atazanavir sulfate [DR:D01276] | Atazanavir [DR:D07471]), Cobicistat [DR:D09881]
Remark
ATC code: J05AR15
Product: D10753<US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV protease [KO:K22599]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR15 Atazanavir and cobicistat
      D10753  Atazanavir and cobicistat <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Atazanavir/ Cobicistat
    D10753  Atazanavir and cobicistat
Antimicrobials [BR:br08307]
 Antivirals
  Polyprotein cleavage inhibitor
   HIV protease inhibitor
    D10753  Atazanavir and cobicistat <US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10753
Other DBs
PubChem: 273220349
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system